Northland raised the firm’s price target on Brainsway (BWAY) to $19 from $15 and keeps an Outperform rating on the shares. BrainsWay beat expectations in Q2 and fundamentals “continue to strengthen,” the analyst tells investors in a post-earnings note.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BWAY:
- Brainsway’s Strong Financial Performance and Strategic Initiatives Justify Buy Rating with Increased Price Target
- Brainsway price target raised to $17 from $16 at H.C. Wainwright
- BrainsWay Reports Strong Q2 2025 Financial Results
- BrainsWay Achieves Record Q2 Revenue and Raises 2025 Guidance
- BrainsWay Secures $20M Financing and Reports Strong Q2 2025 Growth